Transcripts of neurokinin B and neurokinin 3 receptor in superovulated rat ovaries and increased number of corpora lutea as a non-specific effect of intraperitoneal agonist application.
Neurokinin B (NKB), a member of the tachykinin family, and its neurokinin 3 receptor (NK3-R) are preferentially found in the central nervous system. Others have recently reported on mRNA from this ligand-receptor system in the uterus and on NK3-R expression increasing with age. NKB and NK3-R mRNAs have also been noted in cumulus cells and oocytes from superovulated rats. Intact ovaries before and after puberty have not been studied. In this study, we stimulated 29-day-old rats by s.c. injections with gonadotropins for estrous cycle synchronization in order to elucidate the NKB-NK3-R system's expression and function in the ovary. Simultaneously, NaCl, the NK3-R agonist (Pro(7))-NKB, the antagonist SB 218795, or thiorphan, a neutral endopeptidase inhibitor of tachykinin degradation, were injected intraperitoneally (i.p.) for 3 1/2 consecutive days. First, we demonstrated NKB and NK3-R transcripts in one rat ovary by RT-PCR. No significant mRNA differences were noted between immature ovaries and superovulated ovaries in any of the i.p. applications. Second, the possible role of NK3-R on the ovulatory process was verified by counting corpora lutea (CL) and CL cysts in serial sections of the other ovary derived from the four different groups and embedded in paraffin wax. CL and CL cysts were noted in greater numbers in the pharmacologically treated groups than in the saline-treated group. To validate possible drug effects on the peritoneum, we additionally studied pieces of the omentum majus and retroperitoneal fat tissue. Both tissues were heavily infiltrated by granulocytes similar to a non-specific inflammatory response. The saline-treated group as well as the pharmacologically treated groups appeared to develop this unexpected side effect to a similar degree. We conclude that transcripts of NKB and NK3-R are present before and after puberty in the rat ovary and appear to be expressed at similar levels which may indicate a role for the NKB-NK3-R system in follicle growth. The effect of increased CL formation after application of the NK3-R agonist i.p. is related to a non-specific response.
Löffler
Sabine
S
Institute of Anatomy, University of Leipzig, Liebigstrasse 13, D-04103 Leipzig, Germany. Loeffler@medizin.uni-leipzig.de
Schulz
Anett
A
Brylla
Elke
E
Nieber
Karen
K
Spanel-Borowski
Katharina
K
D000818:Animals; D005260:Female; D006064:Gonadotropins, Equine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D007249:Inflammation / Q000139:chemically induced; D007274:Injections, Intraperitoneal; D015287:Neurokinin B / Q000235:genetics*; D010053:Ovary / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism* / Q000473:pathology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D018042:Receptors, Neurokinin-3 / Q000235:genetics*; D013480:Superovulation / Q000187:drug effects / Q000235:genetics*; D014158:Transcription, Genetic / Q000187:drug effects* / Q000235:genetics*
D006064:Gonadotropins, Equine; D012333:RNA, Messenger; D018042:Receptors, Neurokinin-3; D015287:Neurokinin B